SCHEMBL6984820

SCHEMBL6984820

O=S(=O)(Nc1ccc2c(c1)CCCN2)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.61
BRD4 O60885 1/20 0.54
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA9 Q16790 1/20 0.52
PKM P14618 3/20 0.50
PIK3CD O00329 1/20 0.49
ALDH1A1 P00352 3/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
THRB P10828 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
GAA P10253 1/20 0.49
GFER P55789 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
MAPT P10636 2/20 0.48
TP53 P04637 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31681377 0.92 EIF2AK2 (0.54) HTR6BRD4CA12CA1CA2
SCHEMBL7982796 0.92 HTR6 (0.68) HTR6BRD4PKMPIK3CDALDH1A1
SCHEMBL6979531 0.89 HTR6 (0.61) HTR6BRD4PKMALDH1A1LMNA
SCHEMBL6985107 0.87 LMNA (0.67) BRD4CA12CA1CA2CA9
SCHEMBL6985319 0.87 CA12 (0.53) HTR6CA12CA1CA2CA9
SCHEMBL6986758 0.87 PKM (0.56) BRD4CA12CA1CA2CA9
SCHEMBL6982218 0.87 PKM (0.56) HTR6CA12CA1CA2CA9
SCHEMBL2229992 0.86 HTR2C (0.61) BRD4CA12CA1CA2CA9
SCHEMBL6983859 0.86 PKM (0.56) BRD4PKMLMNAMAPTTP53
SCHEMBL6976538 0.86 PKM (0.65) HTR6BRD4CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed